Cover Image
市場調查報告書

臨床實驗管理系統 (CTMS)的全球市場預測 2021年:Web託管、內部部署、雲端基礎

Clinical Trial Management System Market by End-user (Pharmaceutical & Biotechnology, Medical Device Companies, CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Service) - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 229587
出版日期 內容資訊 英文 216 Pages
訂單完成後即時交付
價格
Back to Top
臨床實驗管理系統 (CTMS)的全球市場預測 2021年:Web託管、內部部署、雲端基礎 Clinical Trial Management System Market by End-user (Pharmaceutical & Biotechnology, Medical Device Companies, CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Service) - Global Forecast to 2021
出版日期: 2016年08月12日 內容資訊: 英文 216 Pages
簡介

全球臨床實驗管理系統 (CTMS) 市場規模,預計從2016年到2021年以11.5%的年複合成長率發展,到2021年達到9,200億美元。臨床實驗中的CTMS解決方案的引進擴大,臨床實驗數的增加,及醫藥品、生物醫藥品企業的R&D支出的增加等要素,促進著CTMS市場成長。

本報告提供全球臨床實驗管理系統 (CTMS) 市場現況與展望調查分析,市場概要,影響市場成長因素及市場機會分析,彙整終端用戶、遞送形態、零組件、類型地區等各種區分趨勢與市場規模的變化與預測,競爭環境,主要企業簡介。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • CTMS市場的市場機會
  • 牽引亞太地區預測期間內的CTMS的市場成長
  • 全球CTMS市場:各終端用戶、傳送形態
  • 全球CTMS市場:各零組件、類型

第5章 市場動態

  • 概要
  • 主要的市場成長的促進要素
    • 醫藥品,生命科學及臨床研究產業的R&D支出的增加
    • 臨床實驗數的增加
    • 新產品銷售
    • CTMS解決方案的引進基本客群的增加
    • IT帶來的優點使CTMS的引進增加
  • 主要市場阻礙成長要素
    • 預算的抑制
    • 熟練專家的不足
  • 主要市場機會
    • 亞洲各國的臨床實驗的外包增加
    • 平台即服務 (PaaS) 平台及行動計算的利用
  • 主要的市場趨勢
    • 協同CTMS:HIS,等EMR及EDC的其他軟體和CTMS的整合

第6章 臨床實驗管理系統 (CTMS)的全球市場:各終端用戶

  • 概要
  • 醫藥品、生物醫藥品企業
  • CRO (醫藥品臨床研究委外機構)
  • 醫療設備企業
  • 其他

第7章 臨床實驗管理系統 (CTMS)的全球市場:各傳送形態

  • 概要
  • Web為基礎的 (託管) CTMS
  • 許可證企業 (內部部署) CTMS
  • 雲端基礎 (SaaS) CTMS

第8章 臨床實驗管理系統 (CTMS)的全球市場:各零件

  • 概要
  • 軟體
  • 服務

第9章 臨床實驗管理系統 (CTMS)的全球市場:各類型

  • 概要
  • 企業CTMS
  • 網站CTMS

第10章 臨床實驗管理系統 (CTMS)的全球市場:地區分析

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第11章 臨床實驗管理系統 (CTMS)的全球市場:競爭情報

  • 全球CTMS解決方案市場佔有率:各主要企業
  • 競爭簡介矩陣:3大企業
  • 競爭情形、趨勢

第12章 企業簡介、分析

  • 概要
  • Oracle Corporation
  • Medidata Solutions, Inc.
  • PAREXEL International Corporation
  • BioClinica, Inc. (BioClinica)
  • Bio-Optronics, Inc.
  • Merge Healthcare Incorporated (An IBM Company)
  • DATATRAK International, Inc.
  • Veeva Systems, Inc.
  • DSG Inc. (Document Solutions Group)
  • eClinForce, Inc.
  • ERT
  • Forte Research Systems, Inc.
  • MedNet Solutions, Inc.

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HIT 1686

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across the globe as these solutions significantly increase the efficiency and reduce the cost of conducting clinical trials. Factors such as increasing adoption of CTMS solutions during clinical trials, growing number of clinical trials, and rising R&D expenditure of pharmaceutical and biopharmaceutical companies are driving the growth of the CTMS market. However, dearth of skilled professionals to operate the advanced CTMS solutions and budget constraints of small- and medium-sized pharmaceutical and biotechnology companies and small CROs are restraining the growth of this market.

The global CTMS market has been segmented on the basis of end user (pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies, and others), type (enterprise CTMS and site CTMS), component (software and services), delivery mode (web-based (hosted) CTMS, licensed enterprise (on premise) CTMS, and cloud-based (SaaS) CTMS), and region (North America, Europe, Asia-Pacific, and the Rest of the World).

The contract research organizations segment is estimated to witness the highest growth rate in the global CTMS market, by end user, during the forecast period. Geographically, North America is expected to command the largest share of the global CTMS market in 2016, followed by Europe. The large share of the North American market is primarily driven by the rising number of ongoing clinical trials, rising government support for conducting clinical trials, and presence of a large customer base.

As of 2015, the global CTMS market was dominated by Oracle Corporation (U.S.), Medidata Solutions, Inc. (U.S.), and PAREXEL International Corporation (U.S.), that together accounted for ~60% of the market. New product launches; and partnerships, agreements, and collaborations are the major strategies adopted by market players to strengthen their presence and increase their share in the CTMS market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis-industry analysis, market share analysis of top ten players, and detailed company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth market segments, high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information of CTMS offered by the top 10 market players. The report analyzes the CTMS market by type, end user, component, and delivery mode
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the CTMS market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for CTMS solution across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the CTMS market
  • Competitive Assessment: In-depth assessment of market shares, strategies, and products of leading players in the CTMS market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Markets Covered
  • 1.4. Geographic Scope
  • 1.5. Years Considered for the Study
  • 1.6. Market Segmentation

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
    • 2.1.1. Secondary Data
      • 2.1.1.1. Key Data from Secondary Sources
    • 2.1.2. Primary Data
      • 2.1.2.1. Key Data from Secondary Sources
  • 2.2. Market Size Estimation
    • 2.2.1. Market Size Estimation Steps
    • 2.2.2. End-user Analysis
    • 2.2.3. Bottom-up Approach
    • 2.2.4. Top-up Approach
    • 2.2.5. Primary Research - Sampling Frame
  • 2.3. Data Triangulation And Research Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Introduction
  • 3.2. CTMS Market, by End-user (2016)
  • 3.3. CTMS Market, by Delivery Mode, 2016 Vs. 2021
  • 3.4. CTMS Market Share, by Type, 2016
  • 3.5. CTMS Market share, by Component, 2016
  • 3.6. CTMS Market, by Geography
  • 3.7. Competitive Landscape

4. PREMIUM INSIGHTS

  • 4.1. Market Opportunities For Growth In CTMS Market (2016-2021)
  • 4.2. Asia-pacific To Lead The Market Growth For CTMS During The Forecast Period
  • 4.3. Global CTMS Market, By End-user And Mode Of Delivery (2016)
  • 4.4. global CTMS market, by component and type, 2016 vs. 2021

5. MARKET DYNAMICS

  • 5.1. Overview
  • 5.2. Key Market Drivers
    • 5.2.1. Rising R&D expenditure of pharmaceutical, life science and clinical research industries
    • 5.2.2. Rising number of clinical trials
    • 5.2.3. New product launches
    • 5.2.4. Increasing customer base owing to adoption of CTMS solutions
    • 5.2.5. Rising adoption of CTMS due to advantages provided by it
  • 5.3. Key Market Restraints
    • 5.3.1. Budget constraints
    • 5.3.2. Lack of skilled professionals
  • 5.4. Key Market Opportunities
    • 5.4.1. Increasing outsourcing of clinical trials to CROs in Asian countries
    • 5.4.2. Use of platform-as-a-service (PaaS) platform and mobile computing
  • 5.5. Key Market Trends
    • 5.5.1. collaborative CTMS: integration of CTMS with other software such as HIS, EMR and EDC

6. CTMS MARKET, BY END-USER

  • 6.1. Overview
  • 6.2. Pharmaceutical And Biopharmaceutical Companies
  • 6.3. Contract Research organizations
  • 6.4. Medical Device Companies
  • 6.5. Others

7. CTMS MARKET, BY DELIVERY MODE

  • 7.1. Overview
  • 7.2. Web-Based (Hosted) CTMS
  • 7.3. Licensed Enterprise (On Premise) CTMS
  • 7.4. Cloud-Based (SaaS) CTMS

8. CTMS MARKET, BY COMPONENT

  • 8.1. Overview
  • 8.2. Software
  • 8.3. Services

9. CTMS MARKET, BY COMPONENT

  • 9.1. Overview
  • 9.2. Enterprise CTMS
  • 9.3. Site CTMS

10. GEOGRAPHIC ANALYSIS

  • 10.1. Overview
  • 10.2. North America
    • 10.2.1. Significant number of ongoing clinical trials in the region
    • 10.2.2. Rising government support for clinical trial
  • 10.3. Europe
    • 10.3.1. Government support
    • 10.3.2. Growth in the Biosimilars Market Calls for Increased Clinical Activities
  • 10.4. Asia-Pacific
    • 10.4.1. Increasing number of clinical trials in the region
    • 10.4.2. Government initiatives in the region
  • 10.5. Rest of the World
    • 10.5.1. Favourable clinical trials regulation in Brazil and Mexico
    • 10.5.2. Investment in Middle East

11. COMPETITIVE INTELLIGENCE

  • 11.1. Global CTMS Solutions Market Share, By Key Player, 2015
  • 11.2. Competitive Profile Matrix - Top three players
  • 11.3. Competitive Situation And Trends

12. COMPANY PROFILES AND ANALYSIS

  • 12.1. Overview
  • 12.2. Oracle Corporation
  • 12.3. Medidata Solutions, Inc.
  • 12.4. PAREXEL International Corporation
  • 12.5. BioClinica, Inc. (BioClinica)
  • 12.6. Bio-Optronics, Inc.
  • 12.7. Merge Healthcare Incorporated (An IBM Company)
  • 12.8. DATATRAK International, Inc.
  • 12.9. Veeva Systems, Inc.
  • 12.10. DSG Inc. (Document Solutions Group)
  • 12.11. eClinForce, Inc.
  • 12.12. ERT
  • 12.13. Forte Research Systems, Inc.
  • 12.14. MedNet Solutions, Inc.

13. APPENDIX

  • 13.1. Discussion Guide
  • 13.2. Introducing RT: Real-time Market Intelligence
  • 13.3. Knowledge Store: Marketsandmarkets' Subscription Portal
  • 13.4. Available Customizations
  • 13.5. Related Reports

LIST OF TABLES

  • TABLE 1: Impact Analysis: Drivers
  • TABLE 2: Impact Analysis: Restraints
  • TABLE 3: CTMS Market Size, By End User, 2014-2021 (USD Million)
  • TABLE 4: CTMS Market Size For Pharma And Biopharma Industry, By Region, 2014-2021 (USD Million)
  • TABLE 5: CTMS Market Size For Contract Research Organizations (CRO), By Region, 2014-2021 (USD Million)
  • TABLE 6: CTMS Market Size For Medical Device Manufacturers, By Region, 2014-2021 (USD Million)
  • TABLE 7: CTMS Market Size For Others, By Region, 2014-2021 (USD Million)
  • TABLE 8: Global CTMS Market Size, By Mode Of Delivery, 2014-2021 (USD Million)
  • TABLE 9: Web-hosted (On-demand) CTMS Market Size, By Geography, 2014-2021 (USD Million)
  • TABLE 10: Licensed Enterprise (On-premise) CTMS Market Size, By Geography, 2014-2021 (USD Million)
  • TABLE 11: Cloud-based (SaaS) Market Size, By Geography, 2014-2021 (USD Million)
  • TABLE 12: Global CTMS Market Size, By Component, 2014-2021 (USD Million)
  • TABLE 13: Software Market Size, By Geography, 2014-2021 (USD Million)
  • TABLE 14: Services Market Size, By Geography, 2014-2021 (USD Million)
  • TABLE 15: Global CTMS Market Size, By Type, 2014-2021 (USD Million)
  • TABLE 16: Enterprise CTMS Market Size, By Geography, 2014-2021 (USD Million)
  • TABLE 17: Site CTMS Market Size, By Geography, 2014-2021 (USD Million)
  • TABLE 18: CTMS Market Size, By Geography, 2014-2021 (USD Million)
  • TABLE 19: North America: CTMS Market, By End-user, 2016-2021 (USD Million)
  • TABLE 20: North America: CTMS Market, By Type, 2016-2021 (USD Million)
  • TABLE 21: North America: CTMS Market, By Delivery Mode, 2016-2021 (USD Million)
  • TABLE 22: North America: CTMS Market, By Component, 2016-2021 (USD Million)
  • TABLE 23: Europe: CTMS Market, By End-user, 2016-2021 (USD Million)
  • TABLE 24: Europe: CTMS Market, By Type, 2016-2021 (USD Million)
  • TABLE 25: Europe: CTMS Market, By Delivery Mode, 2016-2021 (USD Million)
  • TABLE 26: Europe: CTMS Market, By Component, 2016-2021 (USD Million)
  • TABLE 27: APAC: CTMS Market, By End-user, 2016-2021 (USD Million)
  • TABLE 28: APAC: CTMS Market, By Type, 2016-2021 (USD Million)
  • TABLE 29: APAC: CTMS Market, By Delivery Mode, 2016-2021 (USD Million)
  • TABLE 30: APAC: CTMS Market, By Component, 2016-2021 (USD Million)
  • TABLE 31: RoW: CTMS Market, by End-user, 2016-2021 (USD MILLION)
  • TABLE 32: RoW: CTMS Market, by Type, 2016-2021 (USD MILLION)
  • TABLE 33: RoW: CTMS Market, by Delivery Mode, 2016-2021 (USD MILLION)
  • TABLE 34: RoW: CTMS Market, by component, 2016-2021 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: CTMS Market Share, By End User, 2016
  • FIGURE 2: CTMS Market Share By End-user (2016-2021)
  • FIGURE 3: R&D Expenditure Of Top 10 Pharmaceutical Companies, 2013 Vs. 2014 (USD Million)
  • FIGURE 4: CTMS Market Share For Pharmaceutical & Biopharmaceutical Companies, by Region (2016)
  • FIGURE 5: CRO Services Cover The Entire Drug Development Spectrum
  • FIGURE 6: Strategic Alliances Between CROS And Pharma Companies (2011-2015)
  • FIGURE 7: CTMS Market Share For Contract Research Organizations (CRO), By Region (2016)
  • FIGURE 8: CTMS Market Share For Medical Device Companies, By Region (2016)
  • FIGURE 9: CTMS Market Share For Other End Users, By Region (2016)
  • FIGURE 10: Global CTMS Market Size, By Mode Of Delivery (2016)
  • FIGURE 11: Web-hosted (On-demand) Segment To Dominate The Global CTMS Solutions Market In 2016
  • FIGURE 12: Web-hosted (On-demand) CTMS Market Share, By Geography (2016)
  • FIGURE 13: Licensed Enterprise (On-premise) CTMS Market Share, By Geography (2016)
  • FIGURE 14: Cloud-based (SaaS) Market Share, By Geography (2016)
  • FIGURE 15: Global CTMS Market Size, By Component, 2016 Vs. 2021
  • FIGURE 16: Software Market Share, By Geography (2016)
  • FIGURE 17: Services Market Share, By Geography (2016)
  • FIGURE 18: Global CTMS Market Share, By Type, 2016 Vs. 2021
  • FIGURE 19: Enterprise CTMS Market Share, By Geography (2016)
  • FIGURE 20: Site CTMS Market Share, By Geography (2016)
  • FIGURE 21: CTMS Market, By Geography (2016)
  • FIGURE 22: TOTAL NUMBER OF ONGOING CLINICAL TRIALS, BY REGION (June 2016)
  • FIGURE 23: U.S.: Presence Of High Number Of Organizations From Demand SideNumber Of Biotechnology R&d Organizations, By State (2014)
  • FIGURE 24: North America: CTMS Market Share, By End-user(2016)
  • FIGURE 25: North America: CTMS Market Share, By Type (2016)
  • FIGURE 26: North America: CTMS Market Share, By Delivery Mode (2016)
  • FIGURE 27: North America: CTMS Market Share, By Component (2016)
  • FIGURE 28: Europe: pharmaceutical R&D expenditure, by country (2012-13), in terms of USD Million
  • FIGURE 29: Europe: CTMS Market Share, By End-user(2016)
  • FIGURE 30: Europe: CTMS Market Share, By Type (2016)
  • FIGURE 31: Europe: CTMS Market Share, By Delivery Mode (2016)
  • FIGURE 32: Europe: CTMS Market Share, By Component (2016)
  • FIGURE 33: APAC: CTMS Market Share, By End-user(2016)
  • FIGURE 34: APAC: CTMS Market Share, By Type (2016)
  • FIGURE 35: APAC: CTMS Market Share, By Delivery Mode (2016)
  • FIGURE 36: APAC: CTMS Market Share, By Component (2016)
  • FIGURE 37: Row: CTMS Market Share, By End-user(2016)
  • FIGURE 38: Row: CTMS Market Share, By Type (2016)
  • FIGURE 39: Row: CTMS Market Share, By Delivery Mode (2016)
  • FIGURE 40: Row: CTMS Market Share, By Component (2016)
  • FIGURE 41: Competitive Situation And Trends
  • FIGURE 42: Geographic Revenue Mix Of The Leading Market Players
  • FIGURE 43: ORACLE CORPORATION: Company Snapshot
  • FIGURE 44: Medidata Solutions, Inc.: Company Snapshot
  • FIGURE 45: PAREXEL International Corporation : Company Snapshot
  • FIGURE 46: Merge Healthcare Incorporated : Company Snapshot
  • FIGURE 47: DATATRAK International, Inc. : Company Snapshot
  • FIGURE 48: Veeva Systems, Inc. : Company Snapshot
Back to Top